Lymphocytic
Lymphoma in a Ferret with a History of Pancreatic Islet Cell Tumor
and Adrenal Tumor: A Case Study
Irina Kim, DVM;
Heather L. Tarpley, DVM; Renato S. Sousa, DVM, MS; and Kenneth S.
Latimer, DVM, PhD
Class of 2005 (Kim)
and Department of Pathology (Tarpley, Sousa, Latimer) College of
Veterinary Medicine, University of Georgia, Athens, GA 30602-7388

Signalment Ferret, Fitch, spayed female,
4-year-old.
Presenting
problem The ferret was presented
for scheduled revaluation of the blood glucose concentration four months
after a partial pancreatectomy and left adrenalectomy. The owner reported
that the ferret appeared to be doing well.
Medical history - Approximately
five months prior to presentation, the patient was diagnosed with
a probable insulinoma
based on intermittent "spacey" episodes and low blood glucose
concentrations. The presence of symmetrical ventral alopecia, elevated
estradiol levels, and a palpable mass in the area of the left adrenal
gland was also suggestive of adrenal disease. The ferret was treated
with 0.5 mg/kg oral prednisone BID to stabilize the blood glucose levels
until surgery could be performed. An exploratory laparotomy was done
to remove the enlarged left adrenal gland and a 5 mm nodule on the
right limb of the pancreas. Histopathology of the pancreatic mass was
consistent with a benign islet cell tumor. The adrenal mass was suggestive
of an adrenocortical spindle cell tumor. Prednisone therapy was tapered
over a two-week period and then discontinued. Subsequent monitoring
of blood glucose concentrations indicated that glucose values were
stable and within the reference range.
Physical
examination On presentation, the patient was bright, alert, and responsive. The
alopecia was resolving and the ferret was gaining weight. The heart
rate was 300 beats per minute and the respiratory rate was 100 breaths
per minute. Body condition score (BCS) was assessed at 2/5 and the
patient weighed 720 g. An enlarged, firm, right mandibular lymph node
measuring approximately 1.6 x 1.0 cm and an enlarged left prescapular
measuring approximately 1.7 x 2.2 cm were palpated. Popliteal lymph
nodes were prominent, but surrounded by a large amount of perinodal
fat. The remainder of the physical examination was unremarkable.
Diagnostic
findings Blood was collected under isoflurane anesthesia from the jugular vein
for a complete blood count (CBC). One week later, the patient returned
for a wedge biopsy of the right mandibular lymph node. Thoracic and
abdominal radiographs, as well as abdominal ultrasound, were performed.
Complete Blood Count -
Analyte
|
Day 1 |
Day 22 |
Units |
Reference
Range*
Fitch Female |
| HCT |
32 L |
44.6 L |
% |
47-51 |
| RBC |
6.79 |
9.44 |
x 106/µl |
|
| Hb |
10.6 L |
14.6 L |
g/dl |
15.2-17.4 |
| Platelets |
484 |
601 |
x 103/µl |
297-910 |
| nRBC |
0 |
0 |
/100 WBC |
|
RBC
morphology
|
Slight
anisocytosis |
|
|
|
| WBC |
3.8 |
5.5 |
x 103/µl |
2.5-8.6 |
| Seg |
2.54 (67%)
H |
3.85 (70%) |
x 103/µl |
12-41 % |
| Band |
0.03 (1%) |
0 |
x 103/µl |
0-4.2 % |
| Lymph |
1.21 (32%) |
1.21 (22%)
L |
x 103/µl |
25-95 % |
| Mono |
0 |
0.22 (4%) |
x 103/µl |
1.7-6.3 % |
| Eos |
0 |
0.22 (4%) |
x 103/µl |
1-9 % |
| Baso |
0 |
0 |
x 103/µl |
0-2.9 % |
| * Lee EJ, et al. |
| Analyte |
Value |
Reference Range |
Method |
| Blood glucose |
72 mg/dl |
63-134 |
Portable glucometer |
Histopathology Histologic examination of the biopsy sample from the right mandibular
lymph node revealed replacement of normal architecture by a diffuse
sheet of homogeneous, small, round cells with scant cytoplasm, small
nuclei with 1 to 2 evident nucleoli, and mild anisokaryosis. There
was 1 mitosis per 10 high power (45x) fields of view (Fig. 1).
 |
| Figure
1. A homogeneous
population of small lymphocytes is present (Ferret, right mandibular
lymph node, hematoxylin and eosin stain). |
Immunohistochemical
staining indicated that the cells were strongly CD3 positive and
CD79a negative. This procedure indicated that the lymphoma was of
T cell origin (Fig. 2 and 3)
 |
 |
| Figure 2. Neoplastic lymphocytes exhibit strong immunohistochemical
staining for CD3 antigen, indicating T lymphocyte origin (Ferret,
right mandibular lymph node, CD3 immunohistochemical staining with
hematoxylin counterstain). |
Figure
3. Neoplastic lymphocytes are unreactive following CD79a staining,
demonstrating that the neoplastic lymphocytes are not of B cell
origin (Ferret, right mandibular lymph node, CD79a immunohistochemical
staining with hematoxylin counterstain). |
Radiography - Thoracic abnormalities were not identified on survey radiographs.
Metallic hemoclips, consistent with a medical history of previous abdominal
surgeries, were identified in the dorsocranial abdomen. The left kidney
appeared slightly smaller than the right kidney.
Abdominal
Ultrasonography - Abdominal ultrasonography identified multiple
hypoechoic lymph nodes throughout the abdominal cavity. The medial
iliac lymph nodes were mildly enlarged and a small amount of peritoneal
effusion was present. Abnormalities were not identified in the liver,
spleen, kidneys, bladder, right adrenal gland, or the right limb of
the pancreas.
Problems
Problem 1 Peripheral and abdominal lymphadenopathy
The differential diagnosis for lymphadenopathy includes inflammation,
lymphoid hyperplasia, and neoplasia. Lymph node cytologic aspirates
or biopsy may help to identify the underlying pathology. A wedge biopsy
of the right mandibular lymph node showed a diffuse population of small
lymphocytes with scant cytoplasm as described above. These findings
were compatible with lymphocytic lymphoma. Abdominal lymphadenopathy
was noted on ultrasonographic examination of the abdominal cavity.
Without aspirates or biopsies, the intra-abdominal presence of lymphoma
could not be confirmed. Underlying gastro-intestinal disease such as
coronavirus or Helicobacter sp. infections also could lead
to enlarged, reactive, abdominal lymph nodes.
Problem 2 - Moderate anemia
The complete blood count (CBC), taken at the time of peripheral lymphadenopathy,
revealed a moderate anemia with a decreased red blood cell (RBC) count
and hemoglobin (Hb) concentration. The reticulocyte count and plasma
protein concentration were not assessed. Anemia may reflect red blood
cell loss, destruction, decreased or ineffective erythropoiesis, or
hemodilution from intravenous fluid administration. The blood sample
was collected under isoflurane anesthesia. In ferrets, isoflurane anesthesia
has been associated with a transient but marked decrease in hematocrit
(Hct), RBC and Hb concentration values. Greater than 30% difference
was noted in these indices when comparing pre-anesthetic and anesthetic
blood samples from individual healthy ferrets. The mechanism of this
phenomenon is unknown.
When the CBC was repeated 22 days later (on the conscious patient),
the Hct and Hb values were just slightly below reference intervals.
Given the variations in the published reference ranges for ferrets,
these values could fall within the low end of the reference range.
Without evidence of hemorrhage, hemolysis, or regeneration, the initial
change in Hct was attributed to the effects of isoflurane.
Problem
3 Mature neutrophilia with lymphopenia
On day 22, the total white blood cell count was within the reference
range but the leukocyte differential count indicated a mature neutrophilia
with a slight lymphopenia. This leukogram pattern was suggestive of
stress associated with endogenous cortisol release.
Diagnosis T-cell
lymphocytic lymphoma
Discussion
In a retrospective study of ferret neoplastic diseases, lymphoma was
identified as the third most common form of neoplasia following pancreatic
islet cell tumors and adrenocortical cell tumors. The ferret in this
case study was afflicted with all three neoplasms. The slow onset of
lymphoma and the apparent lack of clinical signs other than lymphadenopathy
are more characteristic of the adult-onset form of lymphocytic lymphoma
described in ferrets.
The etiology of lymphoma is multifactorial and likely reflects genetic,
environmental, and, possibly, infectious causes. Incidents of cluster
outbreaks of lymphoma in related or cohabitating ferret populations
have led to the speculation of a possible infectious etiology such
as Aleutian parvovirus and feline leukemia virus, but definitive links
have not been demonstrated.
Lymphoma in ferrets can affect peripheral and visceral lymph nodes,
spleen, liver, thymus, bone marrow, kidneys, lungs, and gastrointestinal
tract. In addition, lymphoma can occasionally involve the nervous system
and skin. Anatomic staging of lymphoma in ferrets has followed the
established guidelines for canine lymphoma: Stage I is
localized to a single tumor site, Stage II involves
multiple sites on same side of the diaphragm, Stage III includes
the involvement of the spleen and lymph nodes on both sides of the
diaphragm, and Stage IV describes multiple sites on
both sides of the diaphragm.
Diagnosis of lymphoma is based on the presence of neoplastic lymphoid
cells. Tissue biopsy is recommended to evaluate both cellular morphology
and tissue architecture. The complete blood count, serum biochemical
profile, thoracic and abdominal radiographs, abdominal ultrasonography,
and tissue and bone marrow biopsy or aspirates are useful for staging
the disease.
Histologically, lymphomas have been described by the appearance of
the neoplastic cell population. Small noncleaved cell (SNC) lymphomas,
immunoblastic large cell (IB) lymphomas and immunoblastic polymorphic
(IBP) lymphomas are considered high grade neoplasms and statistically
are associated with a shorter mean survival time than low grade diffuse
small lymphocytic (DSL) lymphoma.
Immunohistochemical staining with T-cell and B-cell markers, such
as anti-CD3 and anti-CD79a antibodies, has been employed in the study
of canine lymphoma as prognostic indicators. As with people, these
studies demonstrated that B-cell lymphomas have a better clinical prognosis
than T-cell lymphomas. In dogs, high grade lymphomas are associated
with better initial response to chemotherapy but a decrease in overall
survival time. Due to the limited number of studies of lymphoma in
ferrets, little information exists on immunophenotype and grade classification
of ferret lymphoma and subsequent response to treatment.
Clinically, lymphoma in ferrets can be described in two general forms
that appear to be associated with age. Ferrets younger than 2 years
of age generally present with an acute, aggressive, multicentric form
of lymphoma. The neoplastic cells are typically high grade SNC or IB
lymphoma cells. Frequently, a mediastinal mass is present but peripheral
lymphadenopathy may not be apparent. Clinical signs of juvenile lymphoma
relate to the organs affected and may include vomiting, diarrhea, and
organomegaly. Coughing or dyspnea may be observed if a compressive,
intrathoracic mass is present. Non-specific clinical signs such as
anorexia, lethargy, and weight loss are frequently seen. Lymphocytosis
has been commonly reported in juvenile lymphoma. Lymphoblasts or abnormal
lymphoid cells are not typically observed in stained blood smears,
but bone marrow involvement is more likely with the juvenile form of
lymphoma. Juvenile lymphoma in ferrets carries a guarded prognosis.
Mature ferrets with lymphoma most often present with chronic, nonspecific
signs such as weight loss and lethargy. Peripheral lymph nodes are
frequently enlarged and firm. Care must be taken when interpreting
the size of popliteal and axillary lymph nodes; large fatty deposits
surround these lymph nodes in mature ferrets. Splenomegaly due to extramedullary
hematopoeisis or neoplastic infiltration may be palpable. As the disease
progresses, other body systems may be affected resulting in variable
clinical signs. On the CBC, lymphopenia is more commonly reported than
lymphocytosis. The histological classification of the lymphoma cells
is variable and may include SNC, IB, IBP and DSL. The diffuse small
cell lymphoma (DSL) is classified as low grade malignancy and is associated
with a longer survival time. Treatment is aimed at diminishing clinical
signs. If remission is achieved, it may last for months to years. In
the retrospective study by Erdmans et al of 60 ferrets with
lymphoma, several mature ferrets lived for years (mean survival of
3.1 years) without any treatment following the clinical diagnosis of
neoplasia.
Treatment options for lymphoma in ferrets include surgical resection
of a localized tumor, chemotherapy, or a combination of the two. Radiation
therapy and alternative medicines also have been attempted. Various
chemotherapeutic protocols have been described for ferrets using oral
and intravenous drugs. Given the difficulty of repeated venous catheterizations,
implanted vascular access ports are useful to maintain long-term venous
access. In general, lymphomas involving the liver, intestines, stomach,
and bone marrow reportedly respond poorly to chemotherapy.
Therapy and Patient Outcome
| Note:
Treatment of animals should only be performed by a licensed
veterinarian. Veterinarians should consult the current literature
and current pharmacological formularies before initiating any
treatment protocol. |
A chemotherapy protocol consisting of L-asparaginase, oral prednisone
and cyclophosphamide was started three weeks after initial presentation
and diagnosis of lymphoma. Two months into treatment, the patient continued
to do well clinically and tolerated the drugs used in the treatment
protocol. The affected lymph nodes had decreased in size and firmness,
but were still enlarged. Prior treatment of this ferret with prednisone
(near the time the pancreatic and adrenal neoplasms were discovered)
may have potentially reduced the tumor burden of this patient resulting
in initial subclinical disease.
References
Brown, SA. Section One - Ferrets, neoplasia. In: Quesenberry
KE, Carpenter J (eds): Ferrets, Rabbits and Rodents: Clinical Medicine
and Surgery. Philadelphia, W B Saunders, 2004, pp. 96-100.
Coleman LA, Erdman SE, Schrenzel MD, Fox JG. Immunophenotypic characterization
of lymphomas from the mediastinum of young ferrets. Am J Vet Res 1998;
59:1281-1286.
Erdman SE, Brown SA, Kawasaki TA, Moore FM, Li X, Fox JG. Clinical
and pathologic findings in ferrets with lymphoma: 60 cases (1982-1994).
J Am Vet Med Assoc 1996; 208:1285-1289.
Erdman SE, Moore FM, Rose R, Fox JG. Malignant lymphoma in ferrets:
Clinical and pathological findings in 19 cases. J Comp Pathol 1992;
106:37-47.
Fournel-Fleury C, Ponce F, Felman P, Blavier A, Bonnefont C, Chabanne
L, Marchal T, Cadore JL, Goy-Thollot I, Ledieu D, Ghernati I, Magnol
JP. Canine T-cell lymphomas: A morphological, immunological, and clinical
study of 46 new cases. Vet Pathol 2002; 39:92-109.
Fournel-Fleury C, Magnol JP, Bricaire P, Marchal T, Chabanne L, Delverdier
A, Bryon PA, Felman P. Cytohistological and immunological classification
of canine malignant lymphomas: comparison with human non-Hodgkin's
lymphomas. J Comp Pathol 1997; 117:35-59.
Lee, EJ, Moore WE, Fryer HC, Minocha HC. Haematological and serum
chemistry profiles of ferrets (Mustela putorius furo). Lab
Animal 1982; 16:133-137.
Li X, Fox JG, Padrid PA. Neoplastic diseases in ferrets: 574 cases
(1968-1997). J Am Vet Med Assoc 1998; 212:1402-1406.
Marini RP, Jackson LR, Esteves MI, Andrutis KA, Goslant CM, Fox JG.
Effect of isoflurane on hematologic variables in ferrets. Am J Vet
Res 1994; 55:1479-1483.
Ponce F, Magnol JP, Ledieu D, Marchal T, Turinelli V, Chalvet-Monfray
K, Fournel-Fleury C. Prognostic significance of morphological subtypes
in canine malignant lymphomas during chemotherapy. Vet J 2004; 167:158-166.
Rassnick KM, Gould WJ 3rd, Flanders JA. Use of a vascular access system
for administration of chemotherapeutic agents to a ferret with lymphoma.
J Am Vet Med Assoc 1995; 206:500-504.
Teske E, van Heerde P, Rutteman GR, Kurzman ID, Moore PF, MacEwen
EG. Prognostic factors for treatment of malignant lymphoma in dogs.
J Am Vet Med Assoc 1994; 205:1722-1728.
Acknowledgement
The image "Sleeping
Ferret Study" by Selina Siu is from her artwork website
and is used with permission. |